Figure 1.

Changes in IPSS and QOL score by the treatment with silodosin (n=91). *Mean ± SD. **p<0.01 by Wilcoxon signed-rank test.

Sakata and Morita BMC Urology 2012 12:29   doi:10.1186/1471-2490-12-29
Download authors' original image